Personalized eHealth program for lifestyle change: results from the "do cardiac health advanced new generated ecosystem (do CHANGE 2)" randomized controlled trial

Do CHANGE consortium; Eva R Broers; Jos Widdershoven; Johan Denollet; Paul Lodder; Willem J Kop; Mart Wetzels; Idowu Ayoola; Jordi Piera-Jimenez; Mirela Habibović

doi:10.1097/PSY.0000000000000802

Personalized eHealth program for lifestyle change: results from the "do cardiac health advanced new generated ecosystem (do CHANGE 2)" randomized controlled trial

Do CHANGE consortium, Eva R Broers, Jos Widdershoven, Johan Denollet, Paul Lodder, Willem J Kop, Mart Wetzels, Idowu Ayoola, Jordi Piera-Jimenez, Mirela Habibović (Corresponding author)

Onderzoeksoutput: Bijdrage aan tijdschrift › Tijdschriftartikel › Academic › peer review

11 Citaten (Scopus)

1 Downloads (Pure)

Samenvatting

OBJECTIVE: Unhealthy lifestyle factors have adverse outcomes in cardiac patients. However, only a minority of patients succeed to change unhealthy habits. Personalization of interventions may result in critical improvements. The current randomized controlled trial provides a proof of concept of the personalized Do CHANGE 2 intervention and evaluates effects on: 1) lifestyle, and 2) quality of life over time.

METHODS: Cardiac patients (N=150; mean age=61.97±11.61 years; 28.7% women; heart failure N=33, coronary artery disease N=50, hypertension N=67) recruited from Spain and The Netherlands were randomized to either the 'Do CHANGE 2' or 'Care as Usual' group. The Do CHANGE 2 group received ambulatory health-behaviour assessment technologies for six months combined with a 3-month behavioural intervention program. Linear Mixed Models (LMM) analysis wERE used to evaluate the intervention effects and latent class analysis (LCA) was used for secondary subgroup analysis.

RESULTS: LMM analysis showed significant intervention effects for lifestyle behaviour (Finteraction(2,138.5)=5.97, p =.003), with improvement of lifestyle behaviour in the intervention group. For quality of life, no significant main effect (F(1,138.18)=.58, p=.447) or interaction effect (F(2,133.1)=0.41, p=.67) were found. Secondary LCA revealed different subgroups of patients per outcome measure. The intervention was experienced as useful and feasible.

CONCLUSION: The personalized eHealth intervention resulted in significant improvements in lifestyle. Cardiac patients and health care providers were also willing to engage in this personalized digital behavioural intervention program. Incorporating eHealth lifestyle programs as part of secondary prevention would be particularly useful when taking into account which patients are most likely to benefit.

TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT03178305.

Originele taal-2	Engels
Pagina's (van-tot)	409-419
Aantal pagina's	11
Tijdschrift	Psychosomatic Medicine
Volume	82
Nummer van het tijdschrift	4
Vroegere onlinedatum	13 mrt. 2020
DOI's	https://doi.org/10.1097/PSY.0000000000000802
Status	Gepubliceerd - 1 mei 2020

Duurzame ontwikkelingsdoelstellingen van de VN

Deze output draagt bij aan de volgende duurzame ontwikkelingsdoelstelling(en)

Toegang tot document

10.1097/PSY.0000000000000802

Andere bestanden en links

Link to publication in Scopus

Citeer dit

Do CHANGE consortium, Broers, E. R., Widdershoven, J., Denollet, J., Lodder, P., Kop, W. J., Wetzels, M., Ayoola, I., Piera-Jimenez, J., & Habibović, M. (2020). Personalized eHealth program for lifestyle change: results from the "do cardiac health advanced new generated ecosystem (do CHANGE 2)" randomized controlled trial. Psychosomatic Medicine, 82(4), 409-419. https://doi.org/10.1097/PSY.0000000000000802

@article{aabecf0034984abe8c08846053e3f99e,

title = "Personalized eHealth program for lifestyle change: results from the {"}do cardiac health advanced new generated ecosystem (do CHANGE 2){"} randomized controlled trial",

abstract = "OBJECTIVE: Unhealthy lifestyle factors have adverse outcomes in cardiac patients. However, only a minority of patients succeed to change unhealthy habits. Personalization of interventions may result in critical improvements. The current randomized controlled trial provides a proof of concept of the personalized Do CHANGE 2 intervention and evaluates effects on: 1) lifestyle, and 2) quality of life over time.METHODS: Cardiac patients (N=150; mean age=61.97±11.61 years; 28.7% women; heart failure N=33, coronary artery disease N=50, hypertension N=67) recruited from Spain and The Netherlands were randomized to either the 'Do CHANGE 2' or 'Care as Usual' group. The Do CHANGE 2 group received ambulatory health-behaviour assessment technologies for six months combined with a 3-month behavioural intervention program. Linear Mixed Models (LMM) analysis wERE used to evaluate the intervention effects and latent class analysis (LCA) was used for secondary subgroup analysis.RESULTS: LMM analysis showed significant intervention effects for lifestyle behaviour (Finteraction(2,138.5)=5.97, p =.003), with improvement of lifestyle behaviour in the intervention group. For quality of life, no significant main effect (F(1,138.18)=.58, p=.447) or interaction effect (F(2,133.1)=0.41, p=.67) were found. Secondary LCA revealed different subgroups of patients per outcome measure. The intervention was experienced as useful and feasible.CONCLUSION: The personalized eHealth intervention resulted in significant improvements in lifestyle. Cardiac patients and health care providers were also willing to engage in this personalized digital behavioural intervention program. Incorporating eHealth lifestyle programs as part of secondary prevention would be particularly useful when taking into account which patients are most likely to benefit.TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT03178305.",

keywords = "behavior change, cardiac health, eHealth, life-style",

author = "{Do CHANGE consortium} and Broers, {Eva R} and Jos Widdershoven and Johan Denollet and Paul Lodder and Kop, {Willem J} and Mart Wetzels and Idowu Ayoola and Jordi Piera-Jimenez and Mirela Habibovi{\'c}",

year = "2020",

month = may,

day = "1",

doi = "10.1097/PSY.0000000000000802",

language = "English",

volume = "82",

pages = "409--419",

journal = "Psychosomatic Medicine",

issn = "0033-3174",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "4",

}

Do CHANGE consortium, Broers, ER, Widdershoven, J, Denollet, J, Lodder, P, Kop, WJ, Wetzels, M, Ayoola, I, Piera-Jimenez, J & Habibović, M 2020, 'Personalized eHealth program for lifestyle change: results from the "do cardiac health advanced new generated ecosystem (do CHANGE 2)" randomized controlled trial', Psychosomatic Medicine, vol. 82, nr. 4, blz. 409-419. https://doi.org/10.1097/PSY.0000000000000802

Personalized eHealth program for lifestyle change: results from the "do cardiac health advanced new generated ecosystem (do CHANGE 2)" randomized controlled trial. / Do CHANGE consortium; Broers, Eva R; Widdershoven, Jos et al.
In: Psychosomatic Medicine, Vol. 82, Nr. 4, 01.05.2020, blz. 409-419.

Onderzoeksoutput: Bijdrage aan tijdschrift › Tijdschriftartikel › Academic › peer review

TY - JOUR

T1 - Personalized eHealth program for lifestyle change

T2 - results from the "do cardiac health advanced new generated ecosystem (do CHANGE 2)" randomized controlled trial

AU - Do CHANGE consortium

AU - Broers, Eva R

AU - Widdershoven, Jos

AU - Denollet, Johan

AU - Lodder, Paul

AU - Kop, Willem J

AU - Wetzels, Mart

AU - Ayoola, Idowu

AU - Piera-Jimenez, Jordi

AU - Habibović, Mirela

PY - 2020/5/1

Y1 - 2020/5/1

N2 - OBJECTIVE: Unhealthy lifestyle factors have adverse outcomes in cardiac patients. However, only a minority of patients succeed to change unhealthy habits. Personalization of interventions may result in critical improvements. The current randomized controlled trial provides a proof of concept of the personalized Do CHANGE 2 intervention and evaluates effects on: 1) lifestyle, and 2) quality of life over time.METHODS: Cardiac patients (N=150; mean age=61.97±11.61 years; 28.7% women; heart failure N=33, coronary artery disease N=50, hypertension N=67) recruited from Spain and The Netherlands were randomized to either the 'Do CHANGE 2' or 'Care as Usual' group. The Do CHANGE 2 group received ambulatory health-behaviour assessment technologies for six months combined with a 3-month behavioural intervention program. Linear Mixed Models (LMM) analysis wERE used to evaluate the intervention effects and latent class analysis (LCA) was used for secondary subgroup analysis.RESULTS: LMM analysis showed significant intervention effects for lifestyle behaviour (Finteraction(2,138.5)=5.97, p =.003), with improvement of lifestyle behaviour in the intervention group. For quality of life, no significant main effect (F(1,138.18)=.58, p=.447) or interaction effect (F(2,133.1)=0.41, p=.67) were found. Secondary LCA revealed different subgroups of patients per outcome measure. The intervention was experienced as useful and feasible.CONCLUSION: The personalized eHealth intervention resulted in significant improvements in lifestyle. Cardiac patients and health care providers were also willing to engage in this personalized digital behavioural intervention program. Incorporating eHealth lifestyle programs as part of secondary prevention would be particularly useful when taking into account which patients are most likely to benefit.TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT03178305.

AB - OBJECTIVE: Unhealthy lifestyle factors have adverse outcomes in cardiac patients. However, only a minority of patients succeed to change unhealthy habits. Personalization of interventions may result in critical improvements. The current randomized controlled trial provides a proof of concept of the personalized Do CHANGE 2 intervention and evaluates effects on: 1) lifestyle, and 2) quality of life over time.METHODS: Cardiac patients (N=150; mean age=61.97±11.61 years; 28.7% women; heart failure N=33, coronary artery disease N=50, hypertension N=67) recruited from Spain and The Netherlands were randomized to either the 'Do CHANGE 2' or 'Care as Usual' group. The Do CHANGE 2 group received ambulatory health-behaviour assessment technologies for six months combined with a 3-month behavioural intervention program. Linear Mixed Models (LMM) analysis wERE used to evaluate the intervention effects and latent class analysis (LCA) was used for secondary subgroup analysis.RESULTS: LMM analysis showed significant intervention effects for lifestyle behaviour (Finteraction(2,138.5)=5.97, p =.003), with improvement of lifestyle behaviour in the intervention group. For quality of life, no significant main effect (F(1,138.18)=.58, p=.447) or interaction effect (F(2,133.1)=0.41, p=.67) were found. Secondary LCA revealed different subgroups of patients per outcome measure. The intervention was experienced as useful and feasible.CONCLUSION: The personalized eHealth intervention resulted in significant improvements in lifestyle. Cardiac patients and health care providers were also willing to engage in this personalized digital behavioural intervention program. Incorporating eHealth lifestyle programs as part of secondary prevention would be particularly useful when taking into account which patients are most likely to benefit.TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT03178305.

KW - behavior change

KW - cardiac health

KW - eHealth

KW - life-style

UR - http://www.scopus.com/inward/record.url?scp=85090429250&partnerID=8YFLogxK

U2 - 10.1097/PSY.0000000000000802

DO - 10.1097/PSY.0000000000000802

M3 - Article

C2 - 32176191

SN - 0033-3174

VL - 82

SP - 409

EP - 419

JO - Psychosomatic Medicine

JF - Psychosomatic Medicine

IS - 4

ER -

Personalized eHealth program for lifestyle change: results from the "do cardiac health advanced new generated ecosystem (do CHANGE 2)" randomized controlled trial

Samenvatting

Duurzame ontwikkelingsdoelstellingen van de VN

Toegang tot document

Andere bestanden en links

Vingerafdruk

Citeer dit